The Medicines and Healthcare products Regulatory Agency (MHRA) have published a consultation on proposals for legislative changes for clinical trials. The consultation aims to amend the existing requirements for clinical trials in the UK, regulated by the Medicines for Human Use (Clinical Trials) Regulations 2004, as amended. Any amendments are intended to streamline approval of clinical trials, enable innovation, enhance…
adminFebruary 18, 2022











